Carolina Perez-Hernandez

Santa Cruz De Tenerife, CN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Effectiveness and Safety of Cabozantinib Treatment in Patients with Advanced Renal Cell Carcinoma in Spanish and Portuguese Real-world Practice: The SOGUG-SPRWEC Study.

Effectiveness and Safety of Cabozantinib Treatment in Patients with Advanced Renal Cell Carcinoma in Spanish and Portuguese Real-world Practice: The SOGUG-SPRWEC Study.

Journal: Clinical genitourinary cancer

Published: April 24, 2025

The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.

The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.

Journal: Therapeutic advances in medical oncology

Published: August 17, 2022

Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial.

Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial.

Journal: Thrombosis and haemostasis

Published: April 05, 2022

External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.

External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.

Journal: Therapeutic advances in medical oncology

Published: February 13, 2021

Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.

Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: November 25, 2020

External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?

External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: June 06, 2020

Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry.

Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry.

Journal: PloS one

Published: April 06, 2020

Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer.

Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer.

Journal: Thrombosis and haemostasis

Published: August 29, 2019

'Supporting a first-time mother': Assessment of success of a breastfeeding promotion programme.

'Supporting a first-time mother': Assessment of success of a breastfeeding promotion programme.

Journal: Midwifery

Published: April 15, 2019

Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma.

Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma.

Journal: Frontiers in genetics

Published: October 08, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026